Mild cases of coccidioidomycosis do not usually require treatment. Most cases of coccidioidomycosis resolve over time. Treatment for severe cases of coccidioidomycosis usually includes anti-fungal medications, cough suppressants, antihistamines, and nonsteroidal anti-inflammatory medications for pain and fever.
Treatment for severe cases of coccidioidomycosis may include:
- Anti-fungal medications for coccidioidomycosis:
- Amphotericin B (AmBisome)
- Ketoconazole (Nizoral)
- Itraconazole (Sporanox)
- Posaconazole (Noxafil)
- Voriconazole (VFEND)
- Caspofungin (Cancidas)
- Cold medications:
- Nonsteroidal anti-inflammatory medications for pain and fever:
- Ibuprofen (Motrin, Advil, Nuprin, NeoProfen)
- Ketoprofen (Actron, Orudis, Oruvail)
- Naproxen (Anaprox, Naprosyn, Aleve)
- Cough suppressants:
Coccidioidomycosis Questions For Doctor
The following are some important questions to ask before and after the treatment of coccidioidomycosis.
Questions to ask before treatment:
- What are my treatment options?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- Am I contagious?
- For how long?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Are there any medications or supplements I should avoid?
- When can I resume my normal activities?
- When can I return to work?
- What else can I do to reduce my risk for complications?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Physicians from the following specialties evaluate and treat coccidioidomycosis:
Continue to Coccidioidomycosis Home Care
- Ampel NM. Combating opportunistic infections: coccidioidomycosis. Expert Opin Pharmacother. 2004 Feb;5(2):255-61. 
- Ampel NM. Introduction. Symposium on coccidioidomycosis. Semin Respir Infect. 2001 Dec;16(4):229-30. 
- Chang A, Tung RC, McGillis TS, Bergfeld WF, Taylor JS. Primary cutaneous coccidioidomycosis. J Am Acad Dermatol. 2003 Nov;49(5):944-9. 
- Deresinski SC. Coccidioidomycosis: efficacy of new agents and future prospects. Curr Opin Infect Dis. 2001 Dec;14(6):693-6.